|
|
|
Xenetic Biosciences (XBIO) CEO Jeffrey Eisenberg at NobleCon17 – Noble Capital Markets 17th Annual Small & Microcap Investor Conference – January 2021. Following the formal presentation, Noble Capital Markets Senior Research Analyst Ahu Demir, PhD joins Jeffrey to moderate a Q&A session. NobleCon 17 Complete Rebroadcast
|
Xenetic Biosciences (XBIO) NobleCon17 Presentation Replay
